產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-phospho-CBL2 (Tyr700)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-CBL2 (Tyr700)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-CBL2 (Tyr700)
Cat. Number:
Anti-phospho-CBL2 (Tyr700)抗體KL-4072R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer Anti-phospho-CBL2 (Tyr700)抗體of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
Also known as:
phospho-C CBL (Tyr700); Anti-phospho-CBL2 (Tyr700)抗體CBL2 (phospho-Tyr700); CBL2 (phospho-Y700); p-CBL2 (Tyr700); p-CBL2 (Y700); C CBL; Cas-Br-M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; CBL 2;E3 ubiquitin protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; RGD1561386; RING finger protein 55; RNF55v Signal transduction protein CBL; 4732447J05Rik; CBL_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated Anti-phospho-CBL2 (Tyr700)抗體synthesised phosphopeptide derived from human C CBL around the phosphorylation site of Tyr700.
●
Predicted Molecular Weight: 100kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-phospho-CBL2 (Tyr700)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-phospho-CBL2 (Tyr700)抗體
Optimal working dilutions must be determined by the end user.
kl154Mu01 纖維蛋白原α(FGα)多克隆抗體 Polyclonal Antibody to Fibrinogen Alpha (FGa)
kl154Ra01 纖維蛋白原α(FGα)多克隆抗體 Polyclonal Antibody to Fibrinogen Alpha (FGa)
kl160Hu01 抗增生抗體靶分子1(TAPA1)多克隆抗體 Polyclonal Antibody to Target Of The Antiproliferative Antibody 1 (TAPA1)
kl162Hu01 硫氧還蛋白結(jié)合蛋白2(TBP2)多克隆抗體 Polyclonal Antibody to Thioredoxin Binding Protein 2 (TBP2)
kl162Mu01 硫氧還蛋白結(jié)合蛋白2(TBP2)多克隆抗體 Polyclonal Antibody to Thioredoxin Binding Protein 2 (TBP2)
kl163Hu01 磷脂爬行酶2(PLSCR2)多克隆抗體 Polyclonal Antibody to Phospholipid Scramblase 2 (PLSCR2)
kl164Hu01 發(fā)動(dòng)蛋白2(DNM2)多克隆抗體 Polyclonal Antibody to Dynamin 2 (DNM2)
kl166Hu01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl166Mu01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl166Ra01 VGF神經(jīng)生長(zhǎng)因子誘導(dǎo)蛋白(VGF)多克隆抗體 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF)
kl167Hu01 CD4分子(CD4)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 4 (CD4)
kl171Hu01 轉(zhuǎn)鐵蛋白受體(TFR)多克隆抗體 Polyclonal Antibody to Transferrin Receptor (TFR)
kl171Ra01 轉(zhuǎn)鐵蛋白受體(TFR)多克隆抗體 Polyclonal Antibody to Transferrin Receptor (TFR)
kl179Hu01 白介素31(IL31)多克隆抗體 Polyclonal Antibody to Interleukin 31 (IL31)
kl179Mu01 白介素31(IL31)多克隆抗體 Polyclonal Antibody to Interleukin 31 (IL31)
kl180Ca01 簇集蛋白(CLU)多克隆抗體 Polyclonal Antibody to Clusterin (CLU)
kl180Hu01 簇集蛋白(CLU)多克隆抗體 Polyclonal Antibody to Clusterin (CLU)
